These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3167148)

  • 21. Dose-catalepsy response to haloperidol in rat: effects of strain and sex.
    Campbell A; Baldessarini RJ; Cremens MC
    Neuropharmacology; 1988 Nov; 27(11):1197-9. PubMed ID: 3205387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
    Nowak K; Welsch-Kunze S; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):385-91. PubMed ID: 3405313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation by haloperidol of the catalepsy produced by lesions in the parafascicular nucleus of the rat.
    Ahlenius S
    Brain Res; 1978 Jul; 150(3):648-52. PubMed ID: 567086
    [No Abstract]   [Full Text] [Related]  

  • 24. Potentiation of haloperidol-induced catalepsy by dopamine agonists: possible involvement of central 5-hydroxytryptamine.
    Carter CJ; Pycock CJ
    Pharmacol Biochem Behav; 1979 Apr; 10(4):475-80. PubMed ID: 572550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex.
    Klockgether T; Schwarz M; Turski L; Sontag KH
    Exp Brain Res; 1988; 70(2):445-7. PubMed ID: 3384045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K; Karcz M; Wardas J; Wolfarth S
    Eur J Pharmacol; 1990 Jul; 182(2):327-34. PubMed ID: 1975782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of antineoplaston A5 on particular subtypes of central dopaminergic receptors.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Mlynarczyk M; Kleinrok Z
    Drugs Exp Clin Res; 1995; 21(4):153-6. PubMed ID: 8529528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social factors influence haloperidol-induced catalepsy in rat.
    Ortiz M; Marquez W; Salazar L; Sanchez S; Davis R; Schreiber HL
    Behav Neural Biol; 1988 Nov; 50(3):344-8. PubMed ID: 3202816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants.
    Barnes DE; Robinson B; Csernansky JG; Bellows EP
    Pharmacol Biochem Behav; 1990 Aug; 36(4):883-7. PubMed ID: 2217518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of haloperidol-induced catalepsy by ascorbic acid in rats and nonhuman primates.
    Dorris RL; Dill RE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):781-3. PubMed ID: 3703914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cataleptogenic effect of haloperidol, chlorpromazine and morphine in developing rats.
    Brus R; Krzemiński T; Piguła J
    Pol J Pharmacol Pharm; 1983; 35(5):377-82. PubMed ID: 6686676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen and haloperidol-induced versus handling-related catalepsy in male rats.
    De Ryck M; Hruska RE; Silbergeld EK
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1027-35. PubMed ID: 7178196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats.
    Shimizu S; Tatara A; Sato M; Sugiuchi T; Miyoshi S; Andatsu S; Kizu T; Ohno Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():157-62. PubMed ID: 24368396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential attenuation of some effects of haloperidol in rats given scopolamine.
    Setler P; Sarau H; McKenzie G
    Eur J Pharmacol; 1976 Sep; 39(1):117-26. PubMed ID: 986946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
    Ward RP; Dorsa DM
    Neuroscience; 1999 Mar; 89(3):927-38. PubMed ID: 10199625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists.
    Malec D
    Pol J Pharmacol; 1997; 49(5):323-7. PubMed ID: 9566031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditional tolerance to haloperidol-induced catalepsy: striatal dopamine receptor supersensitivity is a possible explanation.
    Hoffman DC; Beninger RJ
    Psychopharmacology (Berl); 1988; 95(1):142-5. PubMed ID: 3133695
    [No Abstract]   [Full Text] [Related]  

  • 39. Stimulation of adenosine A2 receptors induces catalepsy.
    Ferré S; Rubio A; Fuxe K
    Neurosci Lett; 1991 Sep; 130(2):162-4. PubMed ID: 1665549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal cocaine treatment reduces haloperidol-induced catalepsy on postnatal day 10.
    Meyer JS; Robinson P; Todtenkopf MS
    Neurotoxicol Teratol; 1994; 16(2):193-9. PubMed ID: 8052194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.